Funding for this research was provided by:
Osaka University
Article History
Received: 27 December 2023
Accepted: 25 February 2024
First Online: 11 May 2024
Declarations
:
: Naohiro Nishida and Daisuke Sakai have no conflicts of interest to declare that are relevant to the content of this article. Taroh Satoh has a position of a board member or advisor: Takara Bio, Inc.; has received honoraria for lectures from Yakult Honsha, Chugai Pharmaceutical, Elli-Lilly, Merck –Serono, Takeda Pharmaceutical, Taiho Pharmaceutical, Ono Pharmaceutical, Bristol-Myers, and Byer; and has received total clinical research grants from Ono pharmaceutical, Elli-Lilly, Chugai Pharmaceutical, MSD, Daiichi-Sankyo, Giliad Sci, Bristol-Myers, and Sanofi-Aventis.